<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03104959</url>
  </required_header>
  <id_info>
    <org_study_id>SLUHN2015-105</org_study_id>
    <nct_id>NCT03104959</nct_id>
  </id_info>
  <brief_title>Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol</brief_title>
  <official_title>Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's Hospital and Health Network, Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Luke's Hospital and Health Network, Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers&#xD;
      over the age of 21. Consent is obtained prior to participation in the study while the&#xD;
      participant is sober. Volunteers are recruited from residency programs, hospital employees,&#xD;
      emergency medical personnel, and friends of the study investigators. If the volunteers choose&#xD;
      to drink, they can participate in the study the night of ingestion of alcohol. There is no&#xD;
      amount we ask them to drink, and we allow them to withdraw from the study at any time. We&#xD;
      never force them to drink alcohol, or even encourage it. The participation is completely&#xD;
      voluntary, if they would like to participate and if they choose to drink alcohol, we ask them&#xD;
      to participate in the placebo controlled study in the safety of their own home. Then&#xD;
      materials for the study are given out prior to their participation. An envelope is given with&#xD;
      the questionnaire, and a small packet containing 3 pills of either NAC or placebo, and a&#xD;
      small smear of Vicks vapor rub concealed in a small packet. At the end of their alcohol&#xD;
      ingestion, the volunteer is asked to estimate the number roof drinks consumed and take 1&#xD;
      capsule per 3 drinks consumed of either 600 mg N-Acetyl-L-Cysteine or placebo capsules. In&#xD;
      the morning, each participant fills out a Hangover Symptom Score questionnaire . A random&#xD;
      number generator is used to determine placebo or NAC first, then the participant is given the&#xD;
      other treatment at their subsequent encounter. Then study is being conducted over a series of&#xD;
      many months, and data can be analyzed by the hangover symptoms scale data when using NAC&#xD;
      compared to placebo. The data will be analyzed using the numerical values of each category&#xD;
      for hangover classification and compare the placebo data to the control data.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    unable to enroll sufficient number of participants&#xD;
  </why_stopped>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">June 6, 2018</completion_date>
  <primary_completion_date type="Actual">June 6, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of hangover improvement as measured by hangover symptoms scale after using N-acetyl cysteine compared to placebo</measure>
    <time_frame>less than 24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Prevention of Hangover Using N-Acety Cysteine</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy volunteers consume alcohol independently and estimate number of drinks then apply Vick's vapor rub under nose and take placebo capsules based on number of drinks consumed and fill out a Hangover Symptom Scale the next morning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N-acetyl cysteine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers consume alcohol independently and estimate number of drinks then apply Vick's vapor rub under nose and take N-Acetyl Cysteine capsules based on number of drinks consumed and fill out a Hangover Symptom Scale the next morning</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>N-acetyl cysteine</intervention_name>
    <arm_group_label>N-acetyl cysteine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age over 21 years&#xD;
&#xD;
          -  able and agrees to drink alcohol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  alcoholism (self-reported)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  reactive airway disease&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  kidney/bladder stones&#xD;
&#xD;
          -  kidney disease&#xD;
&#xD;
          -  liver disease&#xD;
&#xD;
          -  stomach ulcer&#xD;
&#xD;
          -  organ transplant patients&#xD;
&#xD;
          -  dialysis patients&#xD;
&#xD;
          -  allergies to alcohol, eggs, milk, or wheat&#xD;
&#xD;
          -  volunteers taking the following medications: opiate pain medication, activated&#xD;
             charcoal, ampicillin,carbamazepine, cephalosporidine, methicillin, nitroglycerine,&#xD;
             oxacillin, penicillin G, quinicillin&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Luke's Hospital</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lieber CS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health. 2003;27(3):220-31. Review.</citation>
    <PMID>15535450</PMID>
  </reference>
  <reference>
    <citation>Swift R, Davidson D. Alcohol hangover: mechanisms and mediators. Alcohol Health Res World. 1998;22(1):54-60. Review.</citation>
    <PMID>15706734</PMID>
  </reference>
  <reference>
    <citation>Gyamfi MA, Wan YJ. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp Biol Med (Maywood). 2010 May;235(5):547-60. doi: 10.1258/ebm.2009.009249. Review.</citation>
    <PMID>20463294</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>December 12, 2016</study_first_submitted>
  <study_first_submitted_qc>April 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>June 7, 2018</last_update_submitted>
  <last_update_submitted_qc>June 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Luke's Hospital and Health Network, Pennsylvania</investigator_affiliation>
    <investigator_full_name>Holly Stankewicz, D.O.</investigator_full_name>
    <investigator_title>attending physician and faculty emergency medicine residency</investigator_title>
  </responsible_party>
  <keyword>hangovers</keyword>
  <keyword>N-acetyl cysteine</keyword>
  <keyword>alcohol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

